trending Market Intelligence /marketintelligence/en/news-insights/trending/rq-_5m-xrkfob2xmrmubea2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Report: Nordic Capital withdraws bid for Sanofi's European generic drugs unit

Banking Essentials Newsletter December Edition Part 2

Banking Essentials Newsletter - November Edition

University Essentials | COVID-19 Economic Outlook in Banking: Rates and Long-Term Expectations: Q&A with the Experts

Estimating Credit Losses Under COVID-19 and the Post-Crisis Recovery


Report: Nordic Capital withdraws bid for Sanofi's European generic drugs unit

Nordic Capital Ltd. withdrew its bid to acquire Sanofi's European generic drugs unit due to high price expectations, the Financial Times reported, citing people familiar with the matter.

According to the sources, the European private equity firm was considering a team-up with U.S.-based Blackstone Group LP to acquire the unit, which Sanofi is looking to sell for up to €2 billion.

With Nordic Capital out, Advent International Corp., BC Partners Ltd. and Carlyle Group LP, as well as at least one pharma company, remain as bidders for the business, the Financial Times said.

The next deadline for bids is reportedly in April.